| LINE ITEM (USD / %) | FY 2025
FILED 2026-03-28 | FY 2024
FILED 2025-03-29 | FY 2023
FILED 2024-03-30 |
|---|---|---|---|
| Revenue (Total Sales) | $1.87B | $1.64B | $1.56B |
| YoY Revenue Growth % | +14.3% | +4.9% | — |
| Gross Profit | $830.2M | $726.1M | — |
| Gross Margin % | 44.4% | 44.4% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $421.0M | $369.9M | $342.2M |
| Operating Margin % | 22.5% | 22.6% | 21.9% |
| Net Income (GAAP) | $287.6M | $246.2M | $209.9M |
| EBITDA (Normalized) | $488.4M | $428.8M | $398.4M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $415.7M | $293.6M | $274.7M |
| Capital Expenditures (CapEx) | $84.2M | $73.6M | $70.2M |
| Free Cash Flow (FCF) | $331.5M | $220.0M | $204.5M |
| FCF Margin % | 17.7% | 13.4% | 13.1% |
| Return on Invested Capital (ROIC %) | 8.6% | 8.5% | 5.2% |
| Cash & Short-Term Equivalents | $107.6M | — | — |
| Total Debt (Short + Long Term) | $701.6M | $999.7M | $2.02B |
| Total Stockholders' Equity | $3.26B | $2.94B | $4.14B |